Clinical Edge Journal Scan

Gut microbiota and migraine: Is there a link?


 

Key clinical point: Gut microbiota may have a potential casual association with migraine symptoms, with evidence indicating a connection between gut microbiota and increased or decreased risk for migraine.

Major finding : A higher abundance of genus Lactobacillus (inverse variance weighted [IVW] odds ratio [OR] 1.10; P = .004) and family Prevotellaceae (IVW OR 0.89; P = .02) were causally associated with a higher and lower risk for migraine, respectively.

Study details: This study used a two-sample Mendelian randomization framework to assess the causal effects of gut microbiota on migraine risk using 2651 single nucleotide polymorphisms as instrumental variables. Large-scale genome-wide association studies consisting of 18,340 participants from 24 cohorts provided the summary-level statistics for gut microbiota.

Disclosures: This study was funded by the National Key Research and Development Program. The authors declared no conflicts of interest.

Source: Meng X et al. Exploring the role of gut microbiota in migraine risk: A two-sample Mendelian randomization study. Scand J Gastroenterol. 2023 (Dec 27). doi: 10.1080/00365521.2023.2298370

Recommended Reading

Comparative efficacy of anti-CGRP mAb in chronic and high-frequency episodic migraine
Migraine ICYMI
Galcanezumab and rimegepant offer effective options for prevention of episodic migraine
Migraine ICYMI
Galcanezumab and rimegepant offer effective options for prevention of episodic migraine
Migraine ICYMI
Fremanezumab benefits migraine patients with inadequate response to prior preventive medications
Migraine ICYMI
Commentary: Examining CGRP Antagonists for Migraine Relief, January 2024
Migraine ICYMI
Building a Toolkit for the Treatment of Acute Migraine
Migraine ICYMI
Retinal Perfusion Is Reduced During Migraine Attacks
Migraine ICYMI
Dispelling Common Headache Myths
Migraine ICYMI
Elevated odds of motor vehicle crashes in older adults after newly diagnosed migraine
Migraine ICYMI
Considering high-dose EPA/DHA as a primary option for migraine prevention
Migraine ICYMI